Riley Hospital for Children
  



Leukemia


Featured Video

Emerging Therapies for CML


For patients with CML whose disease is not responding to imatinib, also known as Gleevec, there are other treatment options. FDA approved drugs are available for those who are intolerant or resistant ... More


Related Topics

Choose a related topic below

Site Map | Legal Notice | Contact Us | Clarian Health | IU School of Medicine | Residency | Wells Center Research | Volunteers
Visitor Info | Giving Opportunities
© 2000-2005 Indiana University School of Medicine Department of Pediatrics